Targeting autophagy, oxidative stress, and ER stress for neurodegenerative disease treatment

(2022) Targeting autophagy, oxidative stress, and ER stress for neurodegenerative disease treatment. Journal of Controlled Release. pp. 147-175. ISSN 01683659 (ISSN)

Full text not available from this repository.

Abstract

Protein homeostasis is a vital process for cell function and, therefore, disruption of the molecular mechanisms involved in this process, such as autophagy, may contribute to neurodegenerative diseases (NDs). Apart from autophagy disruption, excess oxidative stress and endoplasmic reticulum (ER) stress are additional main molecular mechanisms underlying neurodegeneration, leading to protein aggregation, and mitochondrial dysfunction. Notably, these primary molecular processes are interconnected pathways, which have synergistic effects on each other. Therefore, we propose that targeting of the crosstalk between autophagy, oxidative stress and ER stress simultaneously may play a critical role in healing NDs. NeuroNanoTechnology, as a revolutionized approach, in combination with an in-silico strategy, holds great promise for developing de-novo structures for targeting and modulating neuro-molecular pathways. Accordingly, this review outlines the contributions of autophagy, oxidative stress, and ER stress in neurodegenerative conditions along with a particular focus on the crosstalk among these pathways. Furthermore, we provide a comprehensive discussion on the potential of nanomaterials to target this crosstalk and suggest this potential as a promising opportunity in neuroprotection. © 2022

Item Type: Article
Keywords: Autophagy endoplasmic reticulum stress nanotechnology neurodegeneration oxidative stress Cell death Crosstalk Neurodegenerative diseases Proteins Cell functions Disease treatment Homoeostasis Mitochondrial dysfunction Molecular mechanism Molecular process Protein aggregation carbon nanoparticle cyclodextrin derivative lipid nanoparticle metal nanoparticle metal oxide nanoparticle molecular therapy agent nanomaterial natural product neuroprotective agent polymer nanoparticle silica nanoparticle Alzheimer disease amyotrophic lateral sclerosis autophagy (cellular) degenerative disease disease association disorders of mitochondrial functions futurology human molecular pathology molecular therapy neuromodulation neuropathology neuroprotection nonhuman Parkinson disease Review metabolism Humans
Page Range: pp. 147-175
Journal or Publication Title: Journal of Controlled Release
Journal Index: Scopus
Volume: 345
Identification Number: https://doi.org/10.1016/j.jconrel.2022.03.001
ISSN: 01683659 (ISSN)
Depositing User: خانم ناهید ضیائی
URI: http://eprints.mui.ac.ir/id/eprint/25569

Actions (login required)

View Item View Item